These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 15941808)

  • 21. [Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients].
    Rivero A; López-Cortés L; Castillo R; Verdejo J; García MA; Martínez-Marcos FJ; Díez F; Escribano JC; Canueto J; Lozano F; Pasquau J; Hernández JJ; Márquez M; Kindelán JM;
    Enferm Infecc Microbiol Clin; 2007 May; 25(5):305-10. PubMed ID: 17504683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.
    MMWR Recomm Rep; 2000 Jun; 49(RR-6):1-51. PubMed ID: 10881762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in drug-resistant tuberculosis in the United States, 1993-1996.
    Moore M; Onorato IM; McCray E; Castro KG
    JAMA; 1997 Sep; 278(10):833-7. PubMed ID: 9293991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Present-day treatment of tuberculosis and latent tuberculosis infection.
    Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States.
    Reichler MR; Reves R; Bur S; Ford J; Thompson V; Mangura B; Onorato IM; Valway SE;
    South Med J; 2002 Apr; 95(4):414-20. PubMed ID: 11958239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
    Taylor Z; Nolan CM; Blumberg HM; ; ;
    MMWR Recomm Rep; 2005 Nov; 54(RR-12):1-81. PubMed ID: 16267499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
    Marais BJ; Graham SM; Cotton MF; Beyers N
    J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in diagnosis and treatment of latent tuberculosis infection.
    Chapman HJ; Lauzardo M
    J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice.
    De Cock KM; Grant A; Porter JD
    Lancet; 1995 Apr; 345(8953):833-6. PubMed ID: 7898232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons.
    Lee SS; Meintjes G; Kamarulzaman A; Leung CC
    Respirology; 2013 Aug; 18(6):912-22. PubMed ID: 23682586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany].
    Schaberg T; Hauer B; Haas WH; Hohlfeld J; Kropp R; Loddenkemper R; Loytved G; Magdorf K; Rieder HL; Sagebiel D
    Pneumologie; 2004 Apr; 58(4):255-70. PubMed ID: 15098162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and control of tuberculosis in migrant farm workers. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
    MMWR Recomm Rep; 1992 Jun; 41(RR-10):1-15. PubMed ID: 1630425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essentials of tuberculosis control for the practising physician. Tuberculosis Committee, Canadian Thoracic Society.
    CMAJ; 1994 May; 150(10):1561-71. PubMed ID: 8174026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
    Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
    HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and management of tuberculosis.
    Jerant AF; Bannon M; Rittenhouse S
    Am Fam Physician; 2000 May; 61(9):2667-78, 2681-2. PubMed ID: 10821149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of tuberculosis and other mycobacterial diseases.
    Am Rev Respir Dis; 1983 Jun; 127(6):790-6. PubMed ID: 6859666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.